Elbit Imaging (XTAE:EMITF) 3-Year Share Buyback Ratio : -6.70% (As of Dec. 2024)

View and export this data going back to 1986. Start your Free Trial

What is Elbit Imaging 3-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Elbit Imaging's current 3-Year Share Buyback Ratio was -6.70%.

The historical rank and industry rank for Elbit Imaging's 3-Year Share Buyback Ratio or its related term are showing as below:

XTAE:EMITF' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -180.8 Med: -2.2 Max: 0.8
Current: -6.7

During the past 13 years, Elbit Imaging's highest 3-Year Share Buyback Ratio was 0.80%. The lowest was -180.80%. And the median was -2.20%.

XTAE:EMITF's 3-Year Share Buyback Ratio is ranked worse than
66.67% of 141 companies
in the Diversified Financial Services industry
Industry Median: -1 vs XTAE:EMITF: -6.70

Competitive Comparison of Elbit Imaging's 3-Year Share Buyback Ratio

For the Shell Companies subindustry, Elbit Imaging's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elbit Imaging's 3-Year Share Buyback Ratio Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Elbit Imaging's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Elbit Imaging's 3-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Elbit Imaging 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Elbit Imaging (XTAE:EMITF) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Elbit Imaging 3-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Elbit Imaging's 3-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Elbit Imaging Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Elbit Imaging Ltd (XTAE:EMITF) » Definitions » 3-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

EMITF:USA

Address

3 Shimshon Street, Olympia A Tower, Petach Tikva, ISR, 4900102

Website

http://www.elbitimaging.com

Elbit Imaging Ltd is an Israel based company. The business activity of the group is operated through two segments including Medical industries and devices, and Plots in India. Geographically the business presence is in the region of America, Europe, and ROW. The company derives maximum revenue from the Medical industries and devices segment which operates in the field of life science that includes development, production, and marketing of treatment-oriented medical systems, and for certain cancer diseases in the America region.